Access
Email Verification
Agenda 2024 coming soon...
If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com, subject heading “Call for Papers – Vaccine Technology Summit 2024”.
Agenda 2023
DAY 1: MONDAY, MARCH 20, 2023
0830 - 0930 REGISTRATION AND MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 LESSONS LEARNED FOR THE VACCINES DELIVERY IN DIFFERING SETTINGS
- Looking at the network of vaccines producers to improve quality/quantity control of vaccines
- Engage in vaccines delivery and review the immune rate in countries involved in the global program
- Lessons learned from vaccines production to delivery
Felix Njeumi
Food and Agriculture Organization of the United Nations
Food and Agriculture Organization of the United Nations
1010 - 1040 INNOVATIVE TECHNOLOGIES IN VACCINE MANUFACTURING TO ENSURE RAPID RESPONSE
- Learn more about RNA, protein, and viral vectored platforms
- Understand technologies to ensure speed
- Developing technologies to ensure thermostability
Ingrid Kromann
CEPI
CEPI
1040 - 1100 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1100 - 1130 HOW MERCK CONTINUES TO EXPLORE SPEEDING VACCINE DEVELOPMENT TIMELINES
- Sharing experience on reduced cycle times for Ebola Zaire, COVID-19, and Sudan Vaccine
- Continued efforts to close operations using single-use technologies
- Development of new assays that reduce turnaround times to support rapid release
Kay Hunsberger
Merck
Merck
1130 - 1200 UB-612, A CROSS-PLATFORM COVID-19 VACCINE BOOSTER: PHASE 3 STUDY RESULTS
- Phase 3 RCT of Vaxxinity’s subunit booster across multiple authorized COVID-19 vaccines
- Demonstrated non-inferiority (mRNA) or superiority (adenovirus and inactivated) of neutralizing antibodies
Alexander Rumyantsev
Vaxxinity
Vaxxinity
1200 - 1330 NETWORKING LUNCH & VISIT THE VACCINE TECHNOLOGY EXHIBITION
1330 - 1400 CERAMIC SKIN PATCHES FOR A SILENT PANDEMIC
- Developing ceramic micro-needle array patches for the broadest formulation
- Learn how ‘Outbreak Control’ to prevent epidemics from happening
- Dealing with the silent pandemic
Mike Leeuw
MyLife Technologies
MyLife Technologies
1400 - 1430 COMPACT mRNA PRODUCTION THROUGH PROCESS INTENSIFICATION AND INNOVATION
- Understand the limitations associated with conventional mRNA production solutions
- Learn how process intensification and innovation simplify the production of high-quality mRNA
Kristof Vandekerckhove
Quantoom Biosciences
Quantoom Biosciences
1430 - 1500 MOVING AWAY FROM THE PARENTERAL ROUTE: DEVELOPMENT OF BBV154, THE FIRST LICENSED INTRANASAL SARS-COV
- Introducing intranasal vaccine efficacious against SARS-CoV-2
- Sharing phase 1 and 2 trials confirmed safety and immunogenicity
Raches Ella
Bharat Biotech
Bharat Biotech
1500 - 1530 AFTERNOON COFFEE BREAK IN THE EXHIBIT AREASPONSORED BY MYLIFE TECHNOLOGIES
1530 - 1600 NUCLEIC ACID NANOSTRUCTURES AS ANTIGEN PRESENTATION PLATFORMS
- Introducing nanoparticulate vaccine platforms for vaccinology and clinic
- Understand how DNA nanostructures can control the presentation of antigens
- Demonstrating how this platform can elicit neutralizing humoral immunity against SARS-CoV-2 antigen
Grant Knappe
Massachusetts Institute of Technology
Massachusetts Institute of Technology
1600 - 1630 DRUG TO INHIBIT MYELOID-DERIVED SUPPRESSOR CELLS MDSCS
- Understand the transcription with double-strand oligonucleotides in a specific and durable manner
- Learn how suppression of the myeloid-derived suppressor cells [MDSCs] that suppress T cells
- Activation of CD8T cells and Cd14+HLA-DR by saCEBPa in-vivo and in clinical trials
Nagy Habib
Mina Therapeutics Ltd
Mina Therapeutics Ltd
1630 - 1700 DEVELOPMENT OF A SELF-AMPLIFYING MRNA VACCINE PLATFORM FOR INFECTIOUS DISEASE
- Optimization of the samRNA platform to increase vaccine potency
- Understand humoral and cellular immunity induced by samRNA
- Looking at samRNA SARS-CoV2 vaccine potency in non-human primates and humans
Ciaran Scallan
Gritstone bio
Gritstone bio
1700 - 1800 NETWORKING DRINKS RECEPTION
DAY 2: TUESDAY, MARCH 21, 2023
0900 - 0930 MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 A NOVEL DNA VACCINE PLATFORM WITH THE POTENTIAL TO CREATE NEXT-GENERATION VACCINES
- Introducing a novel PLACCINE vaccine technology platform
- Learn more about the “plug and play†vaccine model against rapidly evolving pathogens
- Proof of concept of monovalent and bivalent SARS-CoV-2 PLACCINE vaccines
Khursheed Anwer
IMUNON Inc.
IMUNON Inc.
1010 - 1040 NOVEL SELF-ASSEMBLING VACCINE FOR INFECTIOUS DISEASE AND CANCER
- Development and use cases for the VaxCelerate platform
- Pre-clinical evaluation of VaxCelerate platform vaccines for Lassa Fever and COVID-19
- Pre-clinical testing of a VaxCelerate platform vaccine targeting HPV-driven tumors
Patrick Reeves
Massachusetts General Hospital | Harvard Medical School
Massachusetts General Hospital | Harvard Medical School
1040 - 1110 PLATFORM DEVELOPMENT – ACCELERATING TIMELINES INTO CLINICS
- Introducing IDT biologika’s platform development principles
- Know more about IDT Biologika proprietary DF-1 platform to manufacture rMVA-X vaccines
- Using new technologies for rapid testing of biological materials: next-generation sequencing (NGS)
Niklas Buck
IDT Biologika GmbH
IDT Biologika GmbH
1110 - 1130 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1130 - 1200 DEVELOPMENT OF NEW QUALITY CONTROL METHODS FOR VETERINARY RABIES VACCINE FOCUSED ON THE 3RS CONCEPT
- Development of a potency assay with reduction of mice
- Development of an in-vitro assay for viral titration
- Development of an ELISA assay for glycoprotein quantification
Beatriz Moreira
TecPar
TecPar
1200 - 1230 ADVANCES IN USING THE T-MAX PRECISIONâ„¢ VACCINE PLATFORM AGAINST MAJOR VIRAL PATHOGENS
- Introducing T-Max vaccines to elicit T cell-mediated effector and memory immune responses
- Understanding the results from pre-clinical studies conducted this year against SARS CoV-2
- Facilitating clinical studies against major swine diseases such as African Swine Fever
Thomas Tillett
MBF Therapeutics
MBF Therapeutics
1230 - 1300 FASTER PROCESS DEVELOPMENT WITH HYBRID MODELING AND KNOWLEDGE TRANSFER
- Understand the role of process development in delivering robust processes in a short time
- Explore novel embedding approach for transversal data analysis
- Learn how advanced ML and hybrid modeling can be exploited to transfer knowledge between projects
Moritz von Stosch
DataHow AG
DataHow AG
1300 - 1315 FEEDBACK & RAFFLE DRAW
1315 - 1430 NETWORKING LUNCH
Key topics for 2024:
- The fundamentals of new vaccine discovery and development
Understand biotech and pharmaceutical industry fundamentals and key market drivers for developing vaccinations from a global perspective. - Exploring new technologies in vaccine delivery for better immune responses
Look for new opportunities and make the clinical case for adopting new technology and techniques for vaccine delivery. - Latest research in genetically-engineered vaccinations and mRNA vaccine technologies
Explore innovations and assess the latest results from tests and trials in biologically-engineered vaccinations and new advancements in DNA and messenger RNA vaccination technologies. - New developments in viral vectors, nucleic acid-based vaccines, and structural vaccinology
Future vaccination strategies and the latest advancements in viral vector-based applications for adapting structural viral vaccine design and development. - Advances in live-attenuated virus vaccines and lessons learned from inactivated vaccines
Hear from leading vaccine developers and build on traditional vaccine approaches for cost-effective and proven methods for developing new vaccines. - Case studies and clinical trials and working with global vaccine manufacturers
Gain insights from leading manufacturers and implement strategies that others in the industry use to ensure successful vaccine delivery.
Sponsorship Opportunities
Join us as a sponsor for this IQ International conference! Reach your target audience, limit competitor influence at the conference and become a keynote speaker, while sharing your company's solutions for this industry.
- Get registration discounts
- Enhance your brand awareness
- Additional marketing opportunities